Morning All..............7 Jul 2020 07:39
Well I just wonder when this RNS will arrive??
At what point do we give up our ambitions with COVIDITY?
It is a tricky one this, a future date for return to trials in America is looking as distant at it was a few months ago, and although there has been some talk about the U.K being an option, I am sure a lot of discussion about second waves and mutations by October means that that is far from a certainty.
We have in my mind a chance nothing more of some kind of deal with Biontech and Avidamab, well the days are ticking towards 12 months, but IMHO Covidity is still there, discussions could be ongoing now, and it is really hard to see how an RNS can be structured with so many unknowns.
My personal feeling is another raise by Vulpes or another 3rd party to see us through to the New Year, allowing time for COVIDITY to gain funding and Avidamab to get our first commercial deal, which will only boost ourr chances of a raise in the New Year at a higher M/Cap. A really hard call, lets see how the dice roll. Have a good day.